Thursday
SESSION 57: MANAGEMENT OF INFECTED GRAFTS AFTER EVAR AND OPEN SURGERY: ROLE OF EVAR FOR MYCOTIC ANEURYSMS
SESSION 57 SCHEDULE
1:00 PM - 1:05 AM Graft Infections After EVAR: How Should They Be Diagnosed And Treated
  Presenter(s):Keith D. Calligaro, MD  
  View Abstract      
1:06 PM - 1:11 PM Treatment Of Infected Grafts After EVAR: Is There Hope
  Presenter(s):Edward Y. Woo, MD  
1:12 PM - 1:17 PM Infection Following EVAR: An Under-Reported Problem With Old Solutions And New Challenges: What Should We Be Doing For This Problem
  Presenter(s):Laura Capoccia, MD, PhD  
1:18 PM - 1:23 PM Does Semiconservative Treatment Of Infected Aortic Grafts And Endografts With Salvage Of The Graft Work: What Are The Requirements To Make It Work
  Presenter(s):Martin Malina, MD, PhD  
1:24 PM - 1:29 PM Diagnosis Of Vascular Prosthetic Graft Infection By PET/SPECT Scanning
  Presenter(s):Clark J. Zeebregts, MD, PhD  
1:30 PM - 1:35 PM How Well Do Cryopreserved Allografts Used In In-Line Reconstructions Work For Aortic Graft Infection: When Should They Not Be Used
  Presenter(s):Peter F. Lawrence, MD  
1:36 PM - 1:41 PM In Situ Reconstruction Is The Preferred Treatment For Aortic Graft Enteric Erosion Or Fistula
  Presenter(s):Thomas C. Bower, MD  
  View Abstract      
1:42 PM - 1:47 PM Endovascular Treatment Of Infected AAAs (Mycotic Aneurysms): Virulence Of The Organism Is Key: Is Surgical Drainage And Debridement Always Necessary
  Presenter(s):Kamphol Laohapensang, MD  
  View Abstract      
1:48 PM - 1:53 PM EVAR Treatment Of Infected AAAs Can Be Effective Long-Term Without Secondary Treatment: What Are The Requirements
  Presenter(s):Boonprasit Kritpracha, MD  
1:54 PM - 1:59 PM Next Generation Antimicrobial Silver-Triclosan Vascular Prosthetic Grafts (Synergy/Maquet): How Good Will They Be And Will They Enable In Situ Repair In Patients With Graft Infections (European Results)
  Presenter(s):Max Zegelman, MD, PhD  
  View Abstract      
2:00 PM - 2:06 PM Panel Discussion
END OF SESSION 57
previous next